Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDC report on Portagen

This article was originally published in The Tan Sheet

Executive Summary

"Clinicians should be aware that powdered [infant] formulas are not sterile products and might contain opportunistic bacterial pathogens," CDC says in April 12 Morbidity & Mortality Weekly Report summarizing premature infant's April 2001 death from meningitis caused by Enterobacter sakazakii. Infant became ill after being tube-fed Portagen, Mead Johnson's nutritional powder for infants who cannot digest or absorb fats. BMS division announced recall of Portagen batch at issue March 29; product is intended for use under doctor's supervision and is not typically sold at retail. In a letter to healthcare professionals April 12, FDA says "several outbreaks" of the infection in neonatal intensive care units worldwide have been associated with milk-based powdered infant formulas. Agency recommends powdered formulas "not be used in neonatal intensive care settings unless there is no alternative available"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel